Error: Could not add to watchlist. X
+ Watchlist

Rich Pharmaceuticals Inc

RCHAD:US
Ticker Change
RCHAD:US has changed to a new ticker symbol
USD
Volume
0
Previous Close
0.00
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Previous Close
0.00
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (USD)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.08%
% Price Change
-0.03%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Rich Pharmaceuticals Inc is a biopharmaceutical company. The Company develops RP-323 (12-O-tetradecanoylphorbol-13-acetate), for the treatment of acute myelogenous leukemia (AML) in refractory patients.
Address
9595 Wilshire Boulevard
Suite 900
Beverly Hills, CA 90045
United States
Phone
1-424-230-7001
  • Ben Chang
    Chairman/Pres/CEO/CFO/Treasurer/Secy
Show More